Eptinezumab Demonstrated Migraine Preventive Efficacy on Day 1 After Dosing: Closed Testing Analysis From PROMISE-1 and PROMISE-2 David W. Dodick,Christopher Gottschalk,Stewart J. Tepper,Deborah I. Friedman,Roger Cady,Jeff Smith,Joe Hirman,Steve SnapinnHEADACHE(2020)引用 3|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要